Skip to main content
Clinical Trials/NCT05038501
NCT05038501
Completed
N/A

Prevalence of Comorbidities in Patients Undergoing Oncosurgeries at Tertiary Cancer Institute in North India

Rajiv Gandhi Cancer Institute & Research Center, India1 site in 1 country150 target enrollmentJuly 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Comorbidities and Coexisting Conditions
Sponsor
Rajiv Gandhi Cancer Institute & Research Center, India
Enrollment
150
Locations
1
Primary Endpoint
To study Coronary Artery disease in patients undergoing Oncosurgeries
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Investigators plan to study the prevalence of comorbidities in patients undergoing oncosurgeries

Detailed Description

Plan to study the prevalence of Coronary Artery Disease, Hypertension, Diabetes Mellitus, Hypothyroidism, History of Corona Virus infection in patients undergoing oncosurgeries. In the Pre anesthesia checkup patients age , sex , Weight in kilograms, Height in centimeters , pulse rate, Blood Pressure will be noted and value\>140/90 mmHg will be taken as hypertensive. History will be obtained about diagnosed Coronary Artery Disease , Diabetes Mellitus, Hypertension , Hypothyroidism , History of previous Corona Virus Infection (RT-PCR Test Positive) .Relevant investigations Electrocardiography and Echocardiography for assessment of Coronary Artery Disease. Fasting or Random Blood Sugar , Thyroid Function Test will be done . Fasting Blood Sugar \>126 milligram/ Decilitre and Random Blood sugar \>200mg/dL will be taken as diabetic. TSH more than 5 micro IU/mL will be hypothyroid .

Registry
clinicaltrials.gov
Start Date
July 1, 2021
End Date
August 31, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Rajiv Gandhi Cancer Institute & Research Center, India
Responsible Party
Principal Investigator
Principal Investigator

Dr Anita Kulkarni

Senior Consultant

Rajiv Gandhi Cancer Institute & Research Center, India

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing Oncosurgeries Age above 40 years .

Exclusion Criteria

  • Age below 40 years Emergency Surgery Patient Refusal

Outcomes

Primary Outcomes

To study Coronary Artery disease in patients undergoing Oncosurgeries

Time Frame: 60 days

Electrocardiography and Echocardiography will be performed. Investigators will measure Blood Pressure , Blood Sugar , Thyroid Function Test and previous Corona Virus Infection

To study Diabetes Mellitus in patients undergoing Oncosurgeries.

Time Frame: 60days

Random Blood Sugar in milligram/Decilitre will be measured.

Secondary Outcomes

  • To study Hypothyroidism in patients undergoing Oncosurgeries(60 days)

Study Sites (1)

Loading locations...

Similar Trials